Clinical Trials Browser

Extensive Stage Lung Small Cell Carcinoma × talazoparib × 90 days × Clear all

NCT04334941 2026-06-05

Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

Phase 2 Active not recruiting

Extensive Stage Lung Small Cell Carcinoma